158 related articles for article (PubMed ID: 37865657)
1. Synthesis of novel coumarin-based thiosemicarbazones and their implications in diabetic management via in-vitro and in-silico approaches.
Zahra SB; Ullah S; Halim SA; Waqas M; Huda NU; Khan A; Binsaleh AY; El-Kott AF; Hussain J; Al-Harrasi A; Shafiq Z
Sci Rep; 2023 Oct; 13(1):18014. PubMed ID: 37865657
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation and molecular modelling of 3-Formyl-6-isopropylchromone derived thiosemicarbazones as α-glucosidase inhibitors.
Basri R; Ullah S; Khan A; Mali SN; Abchir O; Chtita S; El-Gokha A; Taslimi P; Binsaleh AY; El-Kott AF; Al-Harrasi A; Shafiq Z
Bioorg Chem; 2023 Oct; 139():106739. PubMed ID: 37478545
[TBL] [Abstract][Full Text] [Related]
3. Novel Coumarin Containing Dithiocarbamate Derivatives as Potent α-Glucosidase Inhibitors for Management of Type 2 Diabetes.
Mollazadeh M; Mohammadi-Khanaposhtani M; Valizadeh Y; Zonouzi A; Faramarzi MA; Kiani M; Biglar M; Larijani B; Hamedifar H; Mahdavi M; Hajimiri MH
Med Chem; 2021; 17(3):264-272. PubMed ID: 32851964
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of 3-hydroxy-2-naphthohydrazide-based hydrazones and their implications in diabetic management via in vitro and in silico approaches.
Tasleem M; Ullah S; Halim SA; Urooj I; Ahmed N; Munir R; Khan A; El-Kott AF; Taslimi P; Negm S; Al-Harrasi A; Shafiq Z
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300544. PubMed ID: 38013251
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new clioquinol derivatives as potent α-glucosidase inhibitors; molecular docking, kinetic and structure-activity relationship studies.
Wali S; Atia-Tul-Wahab ; Ullah S; Khan MA; Hussain S; Shaikh M; Atta-Ur-Rahman ; Choudhary MI
Bioorg Chem; 2022 Feb; 119():105506. PubMed ID: 34896920
[TBL] [Abstract][Full Text] [Related]
6. Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study.
Ullah H; Khan S; Rahim F; Taha M; Iqbal R; Sarfraz M; Shah SAA; Sajid M; Awad MF; Omran A; Albalawi MA; Abdelaziz MA; Al Areefy A; Jafri I
Molecules; 2022 Oct; 27(20):. PubMed ID: 36296520
[TBL] [Abstract][Full Text] [Related]
7. Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.
Asgari MS; Mohammadi-Khanaposhtani M; Kiani M; Ranjbar PR; Zabihi E; Pourbagher R; Rahimi R; Faramarzi MA; Biglar M; Larijani B; Mahdavi M; Hamedifar H; Hajimiri MH
Bioorg Chem; 2019 Nov; 92():103206. PubMed ID: 31445191
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, α-glucosidase inhibition and molecular docking study of coumarin based derivatives.
Taha M; Shah SAA; Afifi M; Imran S; Sultan S; Rahim F; Khan KM
Bioorg Chem; 2018 Apr; 77():586-592. PubMed ID: 29477126
[TBL] [Abstract][Full Text] [Related]
9. Hetarylcoumarins: Synthesis and biological evaluation as potent α-glucosidase inhibitors.
Chaudhry F; Choudhry S; Huma R; Ashraf M; Al-Rashida M; Munir R; Sohail R; Jahan B; Munawar MA; Khan MA
Bioorg Chem; 2017 Aug; 73():1-9. PubMed ID: 28521172
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, biological evaluation, and molecular docking study of chromen-linked hydrazine carbothioamides as potent α-glucosidase inhibitors.
Basri R; Ullah S; Halim SA; Alharthy RD; Rauf U; Khan A; Hussain J; Al-Ghafri A; Al-Harrasi A; Shafiq Z
Drug Dev Res; 2023 Aug; 84(5):962-974. PubMed ID: 37186392
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro evaluation and molecular docking studies of novel coumarin-isatin derivatives as α-glucosidase inhibitors.
Wang G; Wang J; He D; Li X; Li J; Peng Z
Chem Biol Drug Des; 2017 Mar; 89(3):456-463. PubMed ID: 27616456
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, in vitro α-glucosidase inhibitory activities, and molecular dynamic simulations of novel 4-hydroxyquinolinone-hydrazones as potential antidiabetic agents.
Shayegan N; Haghipour S; Tanideh N; Moazzam A; Mojtabavi S; Faramarzi MA; Irajie C; Parizad S; Ansari S; Larijani B; Hosseini S; Iraji A; Mahdavi M
Sci Rep; 2023 Apr; 13(1):6304. PubMed ID: 37072431
[TBL] [Abstract][Full Text] [Related]
13. A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: Design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates.
Kazmi M; Zaib S; Ibrar A; Amjad ST; Shafique Z; Mehsud S; Saeed A; Iqbal J; Khan I
Bioorg Chem; 2018 Apr; 77():190-202. PubMed ID: 29421697
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study.
Saeedi M; Mohammadi-Khanaposhtani M; Pourrabia P; Razzaghi N; Ghadimi R; Imanparast S; Faramarzi MA; Bandarian F; Esfahani EN; Safavi M; Rastegar H; Larijani B; Mahdavi M; Akbarzadeh T
Bioorg Chem; 2019 Mar; 83():161-169. PubMed ID: 30366316
[TBL] [Abstract][Full Text] [Related]
15. Indole acrylonitriles as potential anti-hyperglycemic agents: Synthesis, α-glucosidase inhibitory activity and molecular docking studies.
Solangi M; Kanwal ; Mohammed Khan K; Saleem F; Hameed S; Iqbal J; Shafique Z; Qureshi U; Ul-Haq Z; Taha M; Perveen S
Bioorg Med Chem; 2020 Nov; 28(21):115605. PubMed ID: 33065441
[TBL] [Abstract][Full Text] [Related]
16. Diphenyl-substituted triazine derivatives: synthesis, α-glucosidase inhibitory activity, kinetics and
Shamim S; Khan KM; Ali M; Mahdavi M; Salar U; Mohammadi-Khanaposhtani M; Faramarzi MA; Ullah N; Taha M
Future Med Chem; 2023 Sep; 15(18):1651-1668. PubMed ID: 37727987
[No Abstract] [Full Text] [Related]
17. Giganteone A and malabaricone C as potential pharmacotherapy for diabetes mellitus.
Sivasothy Y; Leong KH; Loo KY; Adbul Wahab SM; Othman MA; Awang K
Nat Prod Res; 2022 Mar; 36(6):1581-1586. PubMed ID: 33593208
[TBL] [Abstract][Full Text] [Related]
18. Coumarins from Angelica decursiva inhibit α-glucosidase activity and protein tyrosine phosphatase 1B.
Ali MY; Jannat S; Jung HA; Jeong HO; Chung HY; Choi JS
Chem Biol Interact; 2016 May; 252():93-101. PubMed ID: 27085377
[TBL] [Abstract][Full Text] [Related]
19. Synthesis & α-glucosidase inhibitory & glucose consumption-promoting activities of flavonoid-coumarin hybrids.
Sun H; Song X; Tao Y; Li M; Yang K; Zheng H; Jin Z; Dodd RH; Pan G; Lu K; Yu P
Future Med Chem; 2018 May; 10(9):1055-1066. PubMed ID: 29676183
[TBL] [Abstract][Full Text] [Related]
20. Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents.
Tafesse TB; Bule MH; Khoobi M; Faramarzi MA; Abdollahi M; Amini M
Mini Rev Med Chem; 2020; 20(2):134-151. PubMed ID: 31553294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
